Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bourlière

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Gastroenterologie Clinique Et Biologique|November 1, 2006
[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]Marc Bourlière
Gastroenterologie Clinique Et Biologique|April 18, 2003
[Transmission of hepatitis B and C viruses from caregiver to patients: myths and reality]Marc Bourlière
Gastroenterologie Clinique Et Biologique|May 3, 2005
[Inactive carrier of hepatitis B virus]Marc Bourlière
Clinics and Research in Hepatology and Gastroenterology|April 10, 2022
Women and liver: Is woman the future of man?Marc Bourlière
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2012
Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?Marc Bourlière
International Journal of Antimicrobial Agents|January 4, 2019
Hepatitis C virus therapy: No one will be left behindMarc Bourlière, Olivia Pietri
Therapeutic Advances in Infectious Disease|August 29, 2014
An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trialsAstrid Wendt, Marc Bourlière
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C Virus: Current and Evolving Treatments for Genotype 4Tarik Asselah, Marc Bourlière
Antiviral Therapy|February 17, 2007
Optimizing treatment outcomes in chronic hepatitis C: management of non-responseStanislas Pol, Marc Bourlière
Gastroenterologie Clinique Et Biologique|August 16, 2002
[Treatment of chronic hepatitis C in special groups]Marc Bourlière, Philippe Halfon, Isabelle Portal
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Gastroenterologie Clinique Et Biologique|November 1, 2006
[Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B]Marc Bourlière
Gastroenterologie Clinique Et Biologique|April 18, 2003
[Transmission of hepatitis B and C viruses from caregiver to patients: myths and reality]Marc Bourlière
Gastroenterologie Clinique Et Biologique|May 3, 2005
[Inactive carrier of hepatitis B virus]Marc Bourlière
Clinics and Research in Hepatology and Gastroenterology|April 10, 2022
Women and liver: Is woman the future of man?Marc Bourlière
Liver International : Official Journal of the International Association for the Study of the Liver|July 4, 2012
Peripheral blood cytopenia before treatment in HCV patients: is it a limitation for HCV treatment in the era of DAA?Marc Bourlière
International Journal of Antimicrobial Agents|January 4, 2019
Hepatitis C virus therapy: No one will be left behindMarc Bourlière, Olivia Pietri
Therapeutic Advances in Infectious Disease|August 29, 2014
An update on the treatment of genotype-1 chronic hepatitis C infection: lessons from recent clinical trialsAstrid Wendt, Marc Bourlière
Gastroenterology Clinics of North America|November 25, 2015
Hepatitis C Virus: Current and Evolving Treatments for Genotype 4Tarik Asselah, Marc Bourlière
Antiviral Therapy|February 17, 2007
Optimizing treatment outcomes in chronic hepatitis C: management of non-responseStanislas Pol, Marc Bourlière
Gastroenterologie Clinique Et Biologique|August 16, 2002
[Treatment of chronic hepatitis C in special groups]Marc Bourlière, Philippe Halfon, Isabelle Portal
Pageof 19